載入...
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial
BACKGROUND: Pre-operative chemoradiotherapy (CRT) for MRI-defined, locally advanced rectal cancer is primarily intended to reduce local recurrence rates by downstaging tumours, enabling an improved likelihood of curative resection. However, in a subset of patients complete tumour regression occurs i...
Na minha lista:
發表在: | Trials |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5576102/ https://ncbi.nlm.nih.gov/pubmed/28851403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2085-2 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|